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Aim: Septal rebound stretch (SRSsept) reﬂects an inefﬁcient deformation of the septum during systole and is a
potential new echocardiographic tool to predict response to Cardiac Resynchronization Therapy (CRT). However,
there are only limited data on the potential predictive value of SRSsept on echocardiographic response. We
evaluated the predictive value of SRSsept on echocardiographic response to CRT in a large population.
Methods and results: A total of 138 consecutive patients with functional class II–IV heart failure who underwent
CRT were studied. Echocardiography was performed at baseline and after a mean follow-up period of 22 ±
8 months. Echocardiographic response to CRT was deﬁned as a reduction in LV end-systolic volume ≥15%.
Receiver operating characteristic curve analysis was performed to deﬁne the optimal cut-off value for SRSsept.
Multivariable analyses were performed to adjust for potential confounders.
Mean age was 68 ± 8 years (30% female). Mean baseline LV ejection fraction was 26 ± 7%, 51% had ischemic
etiology. LBBB or LBBB like morphology was present in 95% of patients. Mean SRSsept was 4.4 ± 3.2%, 56% of
patients had SRSsept ≥4%. Ninety six patients (70%) were echocardiographic responders. Baseline SRSsept was
signiﬁcantly higher in responders compared to non-responders (5.1 ± 3.2 vs 3.0 ± 2.7, P b 0.001). The optimal
cut-off value for SRSsept to predict response to CRT was 4.0%. After both univariate (OR 3.74, 95% CI 1.72–8.10)
andmultivariate analyses (OR 3.71, 95% CI 1.49–9.2), baseline SRSsept N4% independently predicted the response
to CRT.
Conclusions: Baseline septal rebound stretch is independently associated with echocardiographic response
to CRT.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cardiac resynchronization therapy (CRT) has proven effectiveness in
the treatment of severe heart failure, improving symptoms and quality
of life as well as decreasing mortality in a majority of treated patients
[1–5]. Unfortunately, CRT is ineffective in 30–40% of patients and in
some cases it can evenworsen symptoms [6]. Several echocardiographyardiac resynchronization thera-
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d Ltd. This is an open access article untechniques have been used to aid in patient selection for CRT prior to
implantation with promising results in observational single center
trials. However, no ideal echocardiographic approach for the assess-
ment of dyssynchrony has yet been found. The largest prospective
trial (PROSPECT) [7], showed poor predictive value of several con-
ventional and tissue Doppler-based echocardiographic methods. In re-
cent years, 2D-speckle tracking echocardiography has been used to
assess left ventricular (LV) dyssynchrony with inconsistent results
[8–11]. These time-based mechanical LV-dyssynchrony measurements
did however not take into account the inefﬁcient regional myocardial
deformation during systole, which can be reverted by CRT. Stretching
in the septum during systole can be echocardiographically quantiﬁed
by septal rebound stretch (SRSsept) and is a novel measure for inefﬁ-
cient septal deformation. Although SRSsept has the potential to predict
CRT response, only few studies have been performed [12–14].
Moreover, these studies were small sized and had methodological
limitations. The aim of our current study was to assess the predictive
value of SRSsept on echocardiographic response to CRT in a large
study population.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Selection of patients
From January 2008 to December 2009 one-hundred sixty consecu-
tive patients with chronic heart failure (New York Heart Association
functional class II–IV), LVEF ≤35% and wide QRS complex ≥120 msec
who were scheduled for CRT, were included in the present study. Pa-
tients with pre-existent pacemaker or ICD implantationswere excluded
in order to avoid chronic RV-pacingwhich may affect the assessment of
SRSsept. Also patients with a recent myocardial infarction (b3 months)
or decompensated heart failurewere excluded. Etiologywas considered
ischemic in the presence of signiﬁcant coronary artery disease (≥50%
stenosis in 1 or more of the major epicardial coronary arteries) and/or
history of myocardial infarction or prior revascularization by PCI or
CABG. 22 patients with poor echocardiographic window at baseline
were excluded from the analysis (Fig. 1). All patients were on optimal
medical therapy, including angiotensin-converting enzyme inhibitors
and beta-blockers. This prospective registry was approved by the insti-
tutional board. Baseline characteristics included age, gender, etiology of
heart failure, clinical history, medical therapy, NYHA functional class,
ECG and procedural data were collected prospectively and analyzed
retrospectively. Routine follow-up visits were scheduled at 2 months
post-implant, and then every 6 months thereafter. The routine follow-
up in some of our patients took place in referring hospitals. The clinical
status of all survivals at the closure of the study (December 2013) was
veriﬁed. Data on mortality and hospitalization were collected from
reviewing our hospital records, referring hospitals and by contacting
general practitioners.2.2. The study protocol and echocardiographic data acquisition
All patients underwent 2-dimensional echocardiography prior to
biventricular ICD implantation and at follow-up in the second year
after CRT implantation. The images were obtained on a Vivid 7 ultra-
sound machine (General Electric, Milwaukee, WI) using a 3.5 MHz
transducer at a depth of 16 cm in the parasternal (long- and short
axes) and apical (2 and 4 chambers) views. The images were stored in
cine-loop format by well-trained echocardiographists and reviewed by
an independent cardiologist who was not involved in the study.
The left ventricular end-diastolic diameter (LVEDD), left ventricular
end-diastolic volume (LVEDV), left ventricular end-systolic diameterFig. 1. Title: Flowchart o(LVESD) and left ventricular end-systolic volume (LVESV) were mea-
sured and the LVEF was calculated using Simpson's technique [15].
2.3. LV-dyssynchrony measurement with septal rebound stretch (SRSsept)
The analysis was performed using EchoPac version 7.0.1, General
Electric. The acquisition of the 2D images was performed with at least
40 fps to allow for proper speckle tracking analysis off line. The analysis
was performed by a blinded cardiologist towhomonly gray-scale imag-
ing of the septal wall and aortic ﬂow recordings was available. Longitu-
dinal speckle tracking technique was used to assess the deformation in
the septal wall. The region of interest was set along the endocardial bor-
der from the base to the apex, excluding the apical cap, and adapted to
match thewall thickness and checked visually and adjusted if necessary.
Global wall deformation (i.e., calculated over the entire length of the
wall) was used for analysis. SRSsept was deﬁned as the cumulative
amount of systolic stretch after prematurely terminated shortening
in septum (Fig. 2). The effective septal shortening was deﬁned as the
end-systolic (i.e., at aortic valve closure) value of deformation.
Furthermore, we used the inter-ventricular mechanical delay
(IVMD) to assess the interventricular mechanical dyssynchrony as it
has been reported by the previous study [7] as a predictor of response
to CRT, however, with low sensitivity and speciﬁcity.
The off-line analyses were performed on digitally stored images
by an independent observer (A.G.) blinded to the clinical and other
echocardiographic information. All SRSseptmeasures were additionally
performed by another independent, well trained, and experienced car-
diologist (P.P.D.). Furthermore, these measurements were repeated by
the ﬁrst observer, in order to assess inter-observer and intra-observer
variability. Inter-observer and intra-observer variabilitywere expressed
as standard error of measurement (SEM).
2.4. Echocardiographic response to CRT
Response to CRT was deﬁned as a reduction of ≥15% in LVESV
compared to baseline echocardiographic measurement, at the second
year of echocardiographic follow up [7,11].
2.5. Statistical analysis
Continuous variables are expressed as mean ± SD and a non-
parametric Mann–Whitney U-test was used to analyze differences
between groups. Categorical variables are presented as number andf study population.
Fig. 2. Title: Measurement of SRSsept. Legend: Example of septal rebound stretch (SRSsept)measurement. Global longitudinal deformationmeasured over the entire length of the septum
is represented by the dash white lines. Negative slope of the deformation curve indicates shortening; positive slope indicates stretching. Systolic stretch that occurs after initial shortening
deﬁnes systolic rebound stretch. Ifmore than 1 episode of stretch occurs, the absolute amount of stretch is summed to calculate systolic rebound stretch. In this patientwith high amount of
SRSsept, systolic shortening is interrupted early during systole, resulting in prominent systolic stretching. Note that stretching and shortening occurring after AVC (aortic valve closure) are
ignored for rebound stretch measurement.
Table 1
Baseline characteristics of study population according to echocardiographic response to CRT.
All patients
N = 138
Non-responders
N = 42 (30%)
Responders
N = 96(70%)
P-value
Age (years) 68 ± 8 70 ± 9 67 ± 8 0.05
Male gender 70% 69% 70% 0.93
Ischemic 51% 71% 43% 0.002
Non-ischemic 49% 29% 57%
Atrial ﬁbrillation 23% 24% 23% 0.90
Sinus rhythm 77% 76% 77%
LBBB or LBBB like morphology 95% 93% 97% 0.37
RBBB 5% 7% 3%
QRS duration (ms) 164 ± 23 159 ± 20 167 ± 23 0.05
NYHA functional class 2.6 ± 0.5 2.6 ± 0.5 2.6 ± 0.5 0.83
LVEF (%) 26 ± 7 25 ± 6 26 ± 7 0.52
LV end-diastolic volume (ml) 147 ± 56 150 ± 54 146 ± 57 0.47
LV end-systolic volume (ml) 109 ± 46 111 ± 43 108 ± 48 0.47
Systolic blood pressure (mmHg) 123 ± 18 121 ± 19 124 ± 17 0.20
Diastolic blood pressure (mmHg) 73 ± 11 72 ± 10 73 ± 11 0.36
Medication use
Diuretics 80% 91% 75% 0.04
Beta-blocker 85% 83% 85% 0.75
Ace-inhibitors or AT II 86% 85% 87% 0.69
Spironolacton 44% 55% 40% 0.10
SRSsept (%) 4.4 ± 3.2 3.0 ± 2.7 5.1 ± 3.2 b0.001
IVMD (ms) 43.4 ± 25.5 35.9 ± 21.6 47.2 ± 26.7 0.045
Position of LV-lead 0.814
Posterior/postero-lateral 67% 64% 69%
Lateral 22% 21% 22%
Midcardiac vein 4% 5% 4%
Epicardial 7% 10% 5%
Abbreviations: LVEF= left ventricular ejection fraction, LVEDD= left ventricular end diastolic diameter, LVESD= left ventricular systolic diameter, LVEDV= left ventricular end diastolic
volume, LVESV = left ventricular end systolic volume. SRSsept = systolic rebound stretch in septum. IVMD = inter ventricular mechanical delay.
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Fig. 3. Title: ROC curve for responder. Legend: Receiver operating characteristic curves for
SRSsept with reverse remodeling as outcome. AUC = area under the curve.
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between groups. Paired observations (observations of the same variable
at different time points) were analyzed using the nonparametric
Wilcoxon test. Logistic regression analysis was performed to identify
whether SRSsept and IVMD predicted echocardiographic response. In
themultivariate logistic regression analyses baseline SRSsept as contin-
uous variable and as dichotomized variable deﬁned by the optimal cut-
off value, aswell as IVMDwere analyzed separately after adjustment for
clinical variables (age, gender, LVEF, QRS width, LBBB/RBBB, ischemic/
non-ischemic cardiomyopathy). Receiver operating characteristic
curve analysis was performed to ﬁnd the optimal cut-off value for base-
line SRSsept to predict echocardiographic response. In subsequent analy-
ses, SRSsept was analyzed as a continuous variable and as a dichotomous
variable as deﬁned by the optimal cut-off value. P-values b0.05 were
considered statistically signiﬁcant in all analyses. Statistical analysis was
performed using SPSS statistical software (IBM Corp. Released 2011.
IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.).
3. Results
3.1. Baseline characteristics
Of the 160 patients initially included, 22 patients were excluded due
to poor 2D image quality. Therefore, 138 patients were eventually ana-
lyzed. The baseline characteristics of study population according to
echocardiographic response are summarized in Table 1. Mean age was
68±8 yearswith 70%male gender. 59%had functional class 3 heart fail-
ure. Mean QRS durationwas 164± 23msecwith 95% LBBB or LBBB like
morphology and mean EF was 26 ± 7% with 51% ischemic etiology.
Echocardiographic follow-upwas performed at 22± 8months. Accord-
ing to the predeﬁned criterion of a reduction in LVESV ≥15%, 96 (70%)
patients were classiﬁed as responders to CRT and 42 (30%) as non-
responders. 30 of 42 (71%) non-responders had an ischemic cardio-
myopathy. All patients had optimized medical therapy, including
angiotensin-converting enzyme or angiotensin-receptor antagonist
(86%), beta-blockers (85%), diuretics (80%) and spironolactone (44%)
at maximally tolerated dosages.
3.2. Echocardiographic analysis
LV-dyssynchrony indices were analyzed at baseline and at mean
follow-up of 22 ± 8 months. During analysis of SRSsept, 828 segments
were evaluated and only 3% of segments were excluded from analysis
due to non-valid tracking. The inter- and intra-observer variability for
SRSsept were assessed in 20 randomly selected patients. The standard
error of measurement (SEM) for the inter-observer variability was
0.67. The SEM for the intra-rater variability was 1.04.
3.3. Effects of CRT on echocardiographic parameters
During the follow-up, responders showed a signiﬁcant reduction in
end-systolic and diastolic LV volumes compared with non-responders
(LVESV in responders reduced from 108 ± 48 ml to 60 ± 33, P b 0.001
and in non-responders from 111ml ± 43 to 120 ml ± 41, P = 0.1). Fur-
thermore, a signiﬁcant improvement in LVEF was noted in responders
compared with non-responders (from 26% ± 7 to 45% ± 10, P b 0.001
and from 25% ± 6 to 26% ± 6, P = 0.25 respectively).
3.4. Effects of CRT on clinical outcome
Clinical outcome was assessed after a mean follow-up of 57 ±
12months. During the follow-up 32 combined clinical events occurred.
20 patients died 11 / 42(26.2%) in non-responders group and 9 /
96(9.4%) in responders (P = 0.010). 20 patients were hospitalized due
to worsening of heart failure (11 in non-responders group and 9 in re-
sponders, P = 0.010). Eight patients who died were also hospitalizeddue to heart failure during the follow-up. In the entire population a sig-
niﬁcant improvement in clinical status was noted, with a reduction in
NYHA functional class from 2.6 ± 0.5 to 1.78 ± 0.71 (P b 0.001). The
NYHA class during follow up in the responder group was 1.7 ± 0.7
and in the non-responder group was 2.0 ± 0.6 (P = 0.03).
3.5. Baseline SRSsept and response to CRT
The cumulative amount of systolic stretch after prematurely termi-
nated shortening in septum could be quantiﬁed in 97% of patients. As
displayed in Table 1, the baseline value of SRSsept in non-responders
and responders was signiﬁcantly different (3.0%± 2.7 vs 5.1% ± 3.2 re-
spectively, P b 0.001). Receiver operating characteristic curve analysis
was performed to deﬁne the optimal cut-off value for SRSsept to predict
the echocardiographic response. The area under the curve for SRSsept
was 0.70 (CI 0.59–0.80), and the optimal cut-off value to predict re-
sponse to CRT was N4%, yielding a sensitivity and speciﬁcity of, respec-
tively, 66% and 66% (Fig. 3). When patients divided in 2 groups
according to SRSsept ≥4% versus b4%, 56% of patients had SRSsept
≥4%. Furthermore, SRSsept b4% was more common in male gender
and in patients with ischemic cardiomyopathy. SRSsept N4% was more
common in patients with wider QRS duration (Table 2). In univariate
and multivariate analyses, SRSsept ≥4% independently predicted the
response to CRT (Table 3). In univariate analysis, the QRS duration and
non-ischemic etiology independently predicted the response to CRT.
4. Discussion
In this studywith the largest study population until now,wedemon-
strated a strong and independent association between baseline SRSsept
and echocardiographic response to CRT. These ﬁndings are in line with
previous small studies, and possibly this will be an important new echo-
cardiographic tool in predicting response to CRT.
Speckle tracking imaging technique provides information on defor-
mation of certain segments of the myocardial wall. The timing of maxi-
mum deformation of a certain segment of themyocardial wall has been
used to assess the LV-dyssynchrony. This method, also known as time-
based index, has been studied to predict the response to CRT. These
studies demonstrated, however, conﬂicting results regarding the value
of time-based radial and longitudinal dyssynchrony indices in predic-
tion of CRT response [8,9,11,16–20]. In the EchoCRT trial [21], studying
potential beneﬁt of CRT in patients with chronic heart failure and nar-
row QRS, several echocardiographic techniques including radial strain
(time-based index) did not predict mortality after either CRT or no
CRT. One of the plausible reasons that these time-based indices failed
to predict reverse remodeling after CRT is that these indices look only
Table 2
Baseline characteristics of study population according to SRSsept ≥4% versus b4%.
All patients
N = 138
SRSsept b 4%
N = 59 (44%)
SRSsept ≥ 4%
N = 76 (56%)
P-value
Age (years) 68 ± 8 67 ± 9 69 ± 8 0.226
Male gender 70% 80% 62% 0.026
Ischemic 51% 63% 42% 0.018
Non-ischemic 49% 37% 58%
Atrial ﬁbrillation 23% 27% 20% 0.312
Sinus rhythm 77% 73% 80%
LBBB or LBBB like morphology 95% 93% 97% 0.236
RBBB 5% 7% 3%
QRS duration (ms) 165 ± 23 156 ± 23 171 ± 20 b0.001
NYHA functional class 2.6 ± 0.5 2.6 ± 0.5 2.6 ± 0.5 0.885
LVEF (%) 26 ± 7 27 ± 7 25 ± 7 0.219
LV end-diastolic volume (ml) 147 ± 56 146 ± 56 148 ± 57 0.912
LV end-systolic volume (ml) 109 ± 47 107 ± 46 110 ± 47 0.776
Systolic blood pressure (mmHg) 123 ± 18 125 ± 19 122 ± 17 0.422
Diastolic blood pressure (mmHg) 73 ± 11 72 ± 12 73 ± 10 0.455
All abbreviations were explained in Table 1.
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provide information about stretching (push away) of another segment
at the same time [14].
It is important to stress that septal rebound stretch (SRSsept)
measurement, performed by longitudinal speckle tracking analyses,
does not look at the timing of deformation. However, SRSsept is based
on the amount of stretch in the septal wall after the initial contraction
during systole [12]. SRSsept selectively measures the amount of systolic
stretch that occurs after early shortening and disregards the systolic
pre-stretching and post-systolic shortening, both are inefﬁcient defor-
mations associated with the delayed activated segments. SRSsept as-
sesses the amount of dyssynchrony-related wasted energy that can be
recruited by CRT. Conversion of SRSsept into shortening is one of the
primaryworkingmechanisms throughwhich CRT improves ventricular
function [12]. The value of baseline SRSsept in predicting long-term
prognosis, improvement in LV remodeling and neurohormonal activa-
tion after implantation of CRT device has been recently demonstrated
[13]. Furthermore, SRSsept rather than time delay indices provided
signiﬁcant incremental value over clinical characteristics in prediction
of CRT response [14]. In the current study baseline SRSsept indepen-
dently predicted the echocardiographic response to CRT. Our study, as
far as we can ascertain, is the largest study with 138 included patients
with echocardiographic follow up in all patients at a mean of 22 ±
8 months and provides further evidence for the predictive value of
SRSsept in response to CRT. Deﬁnition of response to CRT is still amatter
of debate. In the present study, we assessed LV reverse remodeling
as response to CRT after a mean 2-year follow-up. Previous study
(REVERSE study) showed that the maximal amount of functional and
LV remodeling improvements was reached at 2 years following CRTTable 3
Uni- and multivariate predictors of response to CRT by logistic regression analysis.
Univariate analysis Multivariate analysis‡
Odds
ratio
95% CI P-value Odds
ratio
95% CI P-value
Age 0.96 0.92–1.01 0.082
Male gender 1.04 0.47–2.27 0.930
Non-ischemic etiology 3.35 1.53–7.33 0.002
QRS duration (ms) 1.02 1.00–1.04 0.049
LBBB versus RBBB 2.32 0.45–12.0 0.317
LVEF (%) 1.03 0.97–1.08 0.349
SRSsept % 1.31 1.12–1.54 0.001 1.38 1.13–1.70 0.002
SRSsept (≥4% vs b4%) 3.74 1.72–8.10 0.001 3.71 1.49–9.22 0.005
IVMD 1.02 1.00–1.04 0.033 1.01 0.98–1.03 0.582
All abbreviations were explained in Table 1.
‡ Predictors analyzed separately after adjustment for age, gender, QRS duration, EF at
baseline, LBBB/RBBB and ischemic/non-ischemic etiology.and these improvements sustained in 5-year follow-up [22]. Therefore,
we used the available echocardiograms at 2 years following the implan-
tation to deﬁne the echocardiographic response to CRT. The most
optimal cut-off value of SRSsept for predicting response to CRT can be
questioned. A previous study [13] used a baseline SRSsept of ≥4.7% in
predicting survival without heart transplantation or assist device. How-
ever, they did not report sensitivity and speciﬁcity of the SRSsept. In our
study the area under the curve for SRSsept was 0.70 and the optimal
cut-off value to predict response to CRT was 4% with both a sensitivity
and speciﬁcity of 66%. We acknowledge that sensitivity and speciﬁcity
are not high and it may be a limitation for SRSsept as dyssynchrony
index.4.1. Clinical application of SRSsept
Non-response is an important and unresolved issue in CRT. The costs
and potential procedure-related complications of CRT underline the im-
portance of identifying CRT nonresponders. Although current patient
selection guidelines for CRT utilize QRS width as a surrogate for
dyssynchrony, the results of our study support the additional value of
SRSsept. Based on our study, a cut-off value of SRSsept ≥ 4% can be
used, but future studies should conﬁrm our ﬁndings.5. Limitations
The present study is a retrospective analysis of prospective registry
of a large single-center cohort of consecutive patients treated with
CRT. We realize that retrospective analysis is inferior to prospective in-
vestigations with prespeciﬁed endpoints and cut-off values. The data
however was collected systematically and longitudinally by indepen-
dent physicians. Furthermore, echocardiogramswere analyzed and val-
idated by independent cardiologists. Although measurement variability
might have been negatively inﬂuenced by the inclusion of patients with
atrial ﬁbrillation, the current study population most closely resembles
daily practice. Strain measurement is sensitive to acute change in load
and the calculations for SRSsept requiremeasurements of timing of aor-
tic valve closure to deﬁne end-systole. However, these measurements
were at different times potentially different loading conditions and
heart rates fromwhich the LV images were acquired. Thus, themarking
of the end-systolic phasemay add a source of potential error to themea-
surements of SRSsept. Non-response to CRT is probably not solely due to
insufﬁcient patient selection. Suboptimal LV-lead placement must also
be considered. However, therewere no differences between responders
and non-responders regarding the location of LV-lead in our study
population. Also unfavorable pacemaker settings can contribute to
27A. Ghani et al. / IJC Heart & Vasculature 7 (2015) 22–27non-response to CRT. Unfortunately, wewere not able to perform echo-
guided optimization after device implantation.
6. Conclusion
Wedemonstrated that stretch-based assessment of LV-dyssynchrony
measured with SRSsept was able to predict echocardiographic response
to CRT. These ﬁndings indicate that baseline SRSsept N4% helps identify-
ing potential CRT responders.
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